Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

dc.contributor.author	Rivero, A.
dc.contributor.author	Pérez Molina, José Antonio
dc.contributor.author	Blasco, A. J.
dc.contributor.author	Asensi Álvarez, Víctor
dc.date.accessioned	2017-10-31T10:48:00Z
dc.date.available	2017-10-31T10:48:00Z
dc.date.issued	2017
dc.identifier.citation	Enfermedades Infecciosas y Microbiología Clínica (2017); doi:10.1016/j.eimc.2017.04.002
dc.identifier.issn	0213-005X
dc.identifier.uri	http://hdl.handle.net/10651/43983
dc.description.statementofresponsibility	Rivero, A., Pérez-Molina, J.A., Blasco, A.J., Arribas, J.R., Asensi, V., Crespo, M., Domingo, P., Iribarren, J.A., Lázaro, P., López-Aldeguer, J., Lozano, F., Martínez, E., Moreno, S., Palacios, R., Pineda, J.A., Pulido, F., Rubio, R., Santos, J., de la Torre, J., Tuset, M., Gatell, J.M.
dc.language.iso	eng
dc.relation.ispartof	Enfermedades Infecciosas y Microbiología Clínica
dc.rights	©,
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019937378&doi=10.1016%2fj.eimc.2017.04.002&partnerID=40&md5=0310435f89d43948b94602e6727a3835
dc.title	Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults
dc.type	journal article
dc.identifier.doi	10.1016/j.eimc.2017.04.002
dc.relation.publisherversion	http://dx.doi.org/10.1016/j.eimc.2017.04.002

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.